Atara Biotherapeutics
Latest round
- Series B
Last raised
- Jan 2014
Total raised
- $52M
Investors
- 8
About Atara Biotherapeutics
Founded in 2012 by founder Isaac Ciechanover and based in California, US, Atara Biotherapeutics, Inc. leverages the natural biology of T cells to create allogeneic T-cell immunotherapies to harness the body's immune system to deliver cells. In January 2024, Atara Biotherapeutics, Inc.3 million shares on the Nasdaq Global Select Market. The transaction is expected to close in the first quarter of 2024, pending regulatory approvals and requirements. Atara's product portfolio includes the EBV T-cell platform, which uses allogeneic T cells to target and destroy disease-causing cells. The company's tab-cel (tabelecleucel), is an investigational therapy designed to treat Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) and other EBV-associated cancers. In addition to tab-cel, Atara is developing several other advanced therapies, including ATA188 for multiple sclerosis and ATA3219, a CAR T therapy targeting CD19 for B-cell malignancies. CAR T cells are genetically engineered T cells designed to recognise and attack specific cancer cells.
Who invested in Atara Biotherapeutics
8 investors across 2 rounds
See all investors in Atara Biotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Atara Biotherapeutics
Who invested in Atara Biotherapeutics?
Atara Biotherapeutics has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Atara Biotherapeutics raised?
Atara Biotherapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Atara Biotherapeutics last raise money?
Atara Biotherapeutics's most recent round on record is a Series B, in Jan 2014.
What does Atara Biotherapeutics do?
Founded in 2012 by founder Isaac Ciechanover and based in California, US, Atara Biotherapeutics, Inc.
Where is Atara Biotherapeutics headquartered?
Atara Biotherapeutics is headquartered in Thousand Oaks, US.
Which VCs invest in companies like Atara Biotherapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Atara Biotherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Atara Biotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.